Cancer Antigen Manufacturers, Suppliers & Companies
-
Manufacturerbased in Sherman Oaks, CALIFORNIA (USA)
T-Cure is a clinical-stage immuno-oncology company developing the next generation of T cell therapies for patients with solid tumors. It is committed to bringing new targets and therapies to the T-Cell Receptor (TCR) field that have a high ...
T-Cure - Model 820TCR - Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1)
The Kita-Kyushu Lung Cancer antigen-1 (KK-LC-1) is a cancer/testis antigen (CTA) that is expressed in multiple solid tumors while restricted to germ line cells in normal tissues. ...
CONTACT SUPPLIER -
Manufacturerbased in Billerica, MASSACHUSETTS (USA)
Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient ...
Autoantibody Profiling Service
Discover and validate autoantibody biomarkers; Sengenics autoantibody biomarker profiling services enable you to discover and validate new biomarkers and biomarker signatures with unmatched specificity and ...
CONTACT SUPPLIER -
Manufacturerbased in Raleigh, NORTH CAROLINA (USA)
Kaio's strategy is to develop and in-license technologies and therapies that enable the body’s own immune system to work more efficiently. The goal is to improve clinical outcomes for patients, increase the number and efficacy of therapeutic options ...
Kaio Therapy - Immune Activation Heat Therapy Technology
, broader markets and competitive advantage within the cancer ...
CONTACT SUPPLIER -
Manufacturerbased in Oxford, UNITED KINGDOM
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer ...
ImmunoBody - Model SCIB2 & iSCIB2 - Cancer Vaccine
SCIB2 is the second cancer vaccine based on the ImmunoBody® technology and encodes a modified antibody engineered to express the cancer antigen NY-ESO-1. This is a well-characterised and ...
CONTACT SUPPLIER -
Manufacturerbased in Philadelphia, PENNSYLVANIA (USA)
Adaptimmune, a leader in T-cell therapy, has clinical trials ongoing for three wholly owned SPEAR T-cells (ADP-A2M4, ADP-A2M4CD8, and ADP-A2AFP) in multiple solid tumor indications. The Company's unique SPEAR (Specific Peptide Enhanced Affinity ...
Adaptimmune - Model ADP-A2M4 (MAGE-A4) - Spear T-Cell Therapy
Our ADP-A2M4 (MAGE-A4) SPEAR T-cell therapy is directed to a member of the MAGE family of cancer testis antigen expressed in a number of solid tumor cell types. The MAGE- A4 antigen is among the ...
CONTACT SUPPLIER -
Manufacturerbased in Berlin, GERMANY
T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer. The company is initially focused on T cell receptor (TCR) engineered T cell therapies (TCR-Ts), a promising modality that holds the ...
Model TK-8001 - TCR-T Targeting MAGE-A1 Positive Solid Tumors
TK-8001 is a CD8 TCR-T specific for the Melanoma-associated Antigen Gene-A1, or MAGE-A1. MAGE-A1 is associated with hallmarks of aggressive cancers and poor clinical prognosis, and there is an emerging body of ...
CONTACT SUPPLIER -
Manufacturerbased in San Diego, CALIFORNIA (USA)
Fate Therapeutics (Nasdaq: FATE) is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for patients with cancer. We believe that better cell therapies start with better cells. To ...
Model FT516 - Natural Killer (NK) Cell
NK cells play a major role in the anti-tumor efficacy of certain tumor-antigen targeting antibodies. NK cells express CD16, an activating receptor that binds to the Fc portion of IgG antibodies. Once activated through CD16, NK cells ...
CONTACT SUPPLIER -
Technologybased in Schlieren, SWITZERLAND
We want to empower people to deal with their malignant cells through their own immune system just like we deal with viral infections. Today’s cancer immunotherapies are powerful but, to the detriment of their effect, not very tumor-selective. ...
Antibody Therapies
a series of highly cancer-targeted and drug-based immunotherapies against intracellular tumor antigens for treatment of a variety of solid tumor malignancies. In addition, the company has a superior trispecific ...
CONTACT SUPPLIER -
Manufacturerbased in Schlieren, SWITZERLAND
Virometix is a clinical stage biotech company pioneering a new class of synthetic vaccines to tackle infectious diseases and cancer. Our structure-based vaccines are designed to direct a precise, robust and sustained immune response. With a ...
Cancer Vaccines
Effective antigen delivery and a strong and durable response is the basis for successful cancer vaccines. The SVLP approach, with its modular and flexible design, the inherent adjuvant properties and other immune ...
CONTACT SUPPLIER -
Manufacturerbased in Dartmouth, NOVA SCOTIA (CANADA)
We Advance Novel Immunotherapies for Hard-to-Treat Cancers. IMV Inc. is a clinical-stage pharmaceutical company that has the potential to make history by developing a first-in-class effective T cell-targeted immune therapy for cancer. We have built ...
IMV - Model Maveropepimut-S (DPX-Survivac) - Generating Cancer-Targeted Killer T Cells
Maveropepimut-S (DPX-Survivac) combines the advantages of the DPX platform and the cancer antigen survivin, is the lead candidate of IMV’s new class of immunotherapies that generates ...
CONTACT SUPPLIER -
Manufacturerbased in Zutphen, NETHERLANDS
Dutch Diagnostics is a dynamic company with over 35 years of combined experience in the field of diagnostics. They supply high-quality diagnostic products for clinical laboratories and professional healthcare to over 80 countries worldwide through a ...
Dutch Diagnostics - Bladder Tumor (BT) Test Kit
The BT test is one of our newer Rapid Tests. Bladder Tumor or Cancer needs to be diagnosed as quickly as possible in order for treatment to be effective. The BT cassette test is an immunochromatographic rapid test for the ...
CONTACT SUPPLIER -
Manufacturerbased in West Vancouver, BRITISH COLUMBIA (CANADA)
Focusing initially on breast cancer, BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) is dedicated to enhancing the lives of people with cancer with limited therapy options by developing novel immunotherapies to fight cancer. ...
BriaCell - Model Bria-IMT - Immunotherapy
Bria-IMT™ (developed from a breast cancer cell line) is a patented (USPTO) immunotherapy approach that directly stimulates the body’s own cancer fighting cells to attack and destroy breast ...
CONTACT SUPPLIER -
Technologybased in San Diego, CALIFORNIA (USA)
We apply cutting-edge science to create innovative therapies that will improve the lives of those who suffer from cancer, intractable pain and COVID-19. Cancer is genetically diverse, highly adaptive, constantly mutating and virtually invisible to ...
-
Manufacturerbased in Austin, TEXAS (USA)
Veravas™ is transforming laboratory medicine with a first of its kind, patented antibody detection platform to address unmet clinical needs. This innovative technology uses proprietary nano-sized magnetic beads to preanalytically clean patient ...
Veravas - Model VeraPrep - Antibody Detection Kit
Multiplex detect antibodies in serum, plasma or saliva. The VeraPrep Antibody Detection Kit provides scientists with a state-of-the-art research tool to easily and quickly develop new tests to multiplex detect and measure immunoglobulins against ...
CONTACT SUPPLIER -
Manufacturerbased in Seattle, WASHINGTON (USA)
window into the adaptive immune system the world hadn’t thought possible. Together, Harlan and his brother Chad, founded Adaptive to meet the worldwide demand for immunosequencing technology. Over the past decade, we have developed our proprietary ...
Adaptive - Model TruTCR - Drug Discovery T-Cell Therapy for Cellular Therapy
We are currently leveraging our TCR discovery capabilities to enable commercialization of novel therapies by collaborators. In the future, we may explore expanding our end-to-end capabilities for the development of cellular therapies and vaccines. ...
CONTACT SUPPLIER -
Manufacturerbased in Virum, DENMARK
Immudex was created in 2009 when it spun off from the diagnostic company Dako, now Agilent. Since then, Immudex has grown in numbers, employees, patents, product lines, partnerships, and customers served. Research, development, and commercial ...
MHC I Dextramer - Model CD8+ T Cells - Identify Antigen-Specific Flow Cytometry
Antigen-specific CD8+ T cells play an important role in the immune response of autoimmune disease, cancer, transplantation, infectious disease, and allergy. MHC I Dextramer® reagents can identify ...
CONTACT SUPPLIER -
Manufacturerbased in Emeryville, CALIFORNIA (USA)
Gritstone is developing targeted immunotherapies for cancer and infectious disease. Gritstone’s approach seeks to generate a therapeutic immune response by leveraging insights into the immune system’s ability to recognize and destroy diseased cells ...
Gritstone - Bispecific Antibody Therapeutic (BiSAb)
Gritstone has a program focused on the development of bispecific antibody (BiSAb) therapeutics using highly tumor-specific antigens, including neoantigens, shared between patients with various solid tumors. Our lead BiSAb candidate ...
CONTACT SUPPLIER -
Manufacturerbased in CALIFORNIA (USA)
AIVITA Biomedical is a biotechnology company developing personalized vaccines that target COVID-19 and the seed of all cancers using our autologous cell platform. We leverage our unique expertise in stem cell growth and directed, high-purity ...
AIVITA - Cancer Immunotherapy
AIVITA’s immunotherapy technology creates personalized vaccines for cancer patients that target and eliminate tumor-initiating cells which are the seed of the disease. Used alone or in parallel with other treatments, ...
CONTACT SUPPLIER -
Manufacturerbased in Niel, BELGIUM
eTheRNA has developed a proprietary and integrated set of platform technologies that are overcoming the challenges facing the development of next generation mRNA therapeutics. Our platform includes mRNA construct design and optimization, proprietary ...
eTheRNA - mRNA Platform
Our mRNA platforms and vast in-house experience help partners quickly optimize, screen and select an mRNA code, develop a candidate, and ensure effective & prime manufacturing of the mRNA from research grade to GMP scale. Our platform’s ...
CONTACT SUPPLIER -
Manufacturerbased in Tokyo, JAPAN
Healios will expand the possibilities for curing diseases to increase and further enrich quality of life through the development and supply of regenerative medicine products as part of the rapid progress of regenerative medicine taking place in the ...
iPS Cell-Derived Gene-Edited NK Cells and Cancer Immuno-oncology
Cancer is the leading cause of death in Japan, with approximately 90% of those deaths said to be caused by solid ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you